|
产品描述
|
Certainly! Here's a suggested format for supplementing and improving the product information for the Rabbit Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody:
---
Rabbit Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody
Storage:
- Store the antibody at -20°C for long-term storage.
- For short-term use, the antibody can be stored at 4°C for up to one month.
- Avoid repeated freeze-thaw cycles to maintain antibody integrity.
- Ensure the vial is tightly sealed and protected from light to preserve activity.
Product Description:
- This Rabbit Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody is designed for the detection of carbamyl-lysine modifications in proteins. Carbamylation is a post-translational modification that can affect protein function and is associated with various pathological conditions.
- The antibody is generated in rabbits, ensuring high specificity and affinity towards carbamyl-lysine residues.
- Supplied as a purified IgG fraction, this antibody is suitable for various immunological assays.
Key Features:
- High Specificity: Targets carbamyl-lysine modifications with minimal cross-reactivity.
- Robust Performance: Suitable for a range of applications including Western blotting, ELISA, and immunohistochemistry.
- Validated: Tested and validated for consistency and reliability in detecting carbamylated proteins.
What's Included:
- 100 µg of Rabbit Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody in PBS, pH 7.4 with 0.02% sodium azide as preservative.
- A datasheet providing detailed instructions for use and optimal dilution recommendations.
Applications:
- Western Blotting: Use to identify and quantify carbamylated proteins in cell lysates or tissue samples.
- ELISA: Suitable for quantitative measurement of carbamyl-lysine levels in various samples.
- Immunohistochemistry: Detects carbamylated proteins in tissue sections, enabling the study of their distribution and localization.
- Research: Ideal for studies investigating the role of protein carbamylation in diseases such as chronic kidney disease, cardiovascular diseases, and other metabolic disorders.
---
This format provides a comprehensive overview of the antibody product and enhances the information available to potential users in research and clinical settings.
|